A detailed history of Signaturefd, LLC transactions in Incyte Corp stock. As of the latest transaction made, Signaturefd, LLC holds 3,266 shares of INCY stock, worth $230,383. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,266
Previous 3,611 9.55%
Holding current value
$230,383
Previous $218,000 1.38%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$57.33 - $68.61 $19,778 - $23,670
-345 Reduced 9.55%
3,266 $215,000
Q2 2024

Jul 29, 2024

BUY
$51.18 - $63.75 $23,082 - $28,751
451 Added 14.27%
3,611 $218,000
Q1 2024

May 03, 2024

BUY
$56.55 - $66.59 $15,834 - $18,645
280 Added 9.72%
3,160 $180,000
Q4 2023

Jan 31, 2024

BUY
$52.16 - $64.19 $22,063 - $27,152
423 Added 17.22%
2,880 $180,000
Q3 2023

Nov 03, 2023

BUY
$57.77 - $65.93 $31,022 - $35,404
537 Added 27.97%
2,457 $141,000
Q2 2023

Aug 01, 2023

SELL
$60.95 - $75.51 $22,246 - $27,561
-365 Reduced 15.97%
1,920 $119,000
Q1 2023

Apr 28, 2023

BUY
$70.23 - $86.01 $35,395 - $43,349
504 Added 28.3%
2,285 $165,000
Q4 2022

Jan 27, 2023

BUY
$67.18 - $84.11 $24,251 - $30,363
361 Added 25.42%
1,781 $143,000
Q3 2022

Nov 08, 2022

SELL
$66.18 - $82.86 $13,633 - $17,069
-206 Reduced 12.67%
1,420 $95,000
Q2 2022

Aug 10, 2022

BUY
$66.18 - $83.18 $33,156 - $41,673
501 Added 44.53%
1,626 $124,000
Q1 2022

May 02, 2022

BUY
$66.02 - $79.71 $12,345 - $14,905
187 Added 19.94%
1,125 $89,000
Q4 2021

Jan 25, 2022

BUY
$63.34 - $74.11 $33,443 - $39,130
528 Added 128.78%
938 $69,000
Q3 2021

Oct 28, 2021

BUY
$68.67 - $84.02 $686 - $840
10 Added 2.5%
410 $28,000
Q2 2021

Jul 26, 2021

BUY
$79.87 - $87.53 $5,031 - $5,514
63 Added 18.69%
400 $34,000
Q1 2021

Apr 30, 2021

SELL
$76.02 - $100.5 $14,823 - $19,597
-195 Reduced 36.65%
337 $27,000
Q4 2020

Feb 11, 2021

SELL
$80.74 - $97.7 $10,253 - $12,407
-127 Reduced 19.27%
532 $46,000
Q3 2020

Nov 03, 2020

BUY
$85.07 - $109.69 $1,956 - $2,522
23 Added 3.62%
659 $59,000
Q2 2020

Jul 30, 2020

BUY
$74.18 - $108.93 $5,786 - $8,496
78 Added 13.98%
636 $66,000
Q1 2020

Apr 23, 2020

BUY
$63.18 - $85.97 $22,239 - $30,261
352 Added 170.87%
558 $41,000
Q4 2019

Feb 05, 2020

BUY
$73.04 - $95.72 $4,236 - $5,551
58 Added 39.19%
206 $18,000
Q3 2019

Oct 16, 2019

SELL
$72.82 - $86.52 $6,699 - $7,959
-92 Reduced 38.33%
148 $11,000
Q2 2019

Jul 31, 2019

BUY
$73.52 - $88.7 $6,249 - $7,539
85 Added 54.84%
240 $20,000
Q1 2019

May 09, 2019

BUY
$63.56 - $88.17 $2,161 - $2,997
34 Added 28.1%
155 $13,000
Q4 2018

Feb 13, 2019

BUY
$58.5 - $69.94 $1,053 - $1,258
18 Added 17.48%
121 $8,000
Q3 2018

Nov 15, 2018

SELL
$61.75 - $74.23 $25,379 - $30,508
-411 Reduced 79.96%
103 $7,000
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $24,948 - $34,431
410 Added 394.23%
514 $34,000
Q1 2018

May 08, 2018

BUY
$83.06 - $100.98 $8,638 - $10,501
104 New
104 $9,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.